Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 31 March, 2020

Legg Mason, Inc.

Form 8.3 - Allergan PLC

RNS Number : 2743I
Legg Mason, Inc.
31 March 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

Legg Mason

Companydealtin

Allergan Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate 2)

IE00BY9D5467

Date of dealing

30/3/2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

4,115,007  1.25

 


(2) Derivatives (other than options)



(3)Optionsandagreementstopurchase/sell



Total

4,115,007  1.25

 


 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:

Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities



 

(2) Derivatives (other than options)



 

(3)Optionsandagreementstopurchase/sell



Total




Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

Sale

Sale

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

383

62

832

 

 

 

$174.31

$175.21

$175.24

 

 

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(Note 5)





 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)








 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit 5)




 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

decrease of 24,405 shares

Account maintenance - account(s) transferred out



Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

31/3/2020


Shirley Hinton

Telephone number

+1 410 454 5632

aconnectedEFM,nameofofferee/offerorwithwhichconnected

n/a

If aconnectedEFM,statenatureofconnection (Note 10)

n/a

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEALDFDEKEEFA

a d v e r t i s e m e n t